What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria

The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysio...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Journal of physiology Ročník 601; číslo 18; s. 4013 - 4032
Hlavní autori:	Dasí, Albert, Pope, Michael T.B., Wijesurendra, Rohan S., Betts, Tim R., Sachetto, Rafael, Bueno‐Orovio, Alfonso, Rodriguez, Blanca
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Wiley Subscription Services, Inc 01.09.2023 John Wiley and Sons Inc
Predmet:	Action Potentials - physiology Amiodarone Amiodarone - pharmacology Amiodarone - therapeutic use Atrial Fibrillation - drug therapy Atrium Calcium currents Cardiac arrhythmia Cardiovascular Clinical trials Drug therapy Electrophysiology Fibrillation Flecainide - pharmacology Flecainide - therapeutic use Heart Atria Humans Na+/K+-exchanging ATPase Patients Phenotyping Voltage atrial fibrillation ionic currents low voltage areas in silico drug trials
ISSN:	0022-3751, 1469-7793, 1469-7793
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!